GenTel BioSciences, Inc. Launches APiX(TM) Disease Profiling Kit to Enable Condition-Focused Proteomics Research and Discovery

MADISON, Wis.--(BUSINESS WIRE)--Gentel Biosciences, a leader in proteomics discovery tools, announces the availability of the APiX™ Disease Profiling Kit, a robust, cost-effective single-capture antibody array and detection kit suitable for profiling hundreds of disease-related proteins across multiple disease states.

Back to news